Patents

GeoVax Secures Patent for Innovative Malaria Vaccine Design
GeoVax Labs, Inc. has been granted a U.S. patent for a novel vaccine construct aimed at preventing malaria, marking a significant step forward in the fight against the disease and other infectious threats.

Lexaria Bioscience Corp. Achieves Global Patent Milestone with 50 Patents
Lexaria Bioscience Corp. has reached a significant milestone with 50 patents granted worldwide, including new patents for epilepsy treatment and sublingual nicotine delivery, marking a pivotal moment in the company's strategy to expand its drug delivery platform.

Nutriband Inc. Secures U.S. Patent for AVERSA(TM) Technology, Aiming to Curb Drug Abuse
Nutriband Inc.'s new U.S. patent for its AVERSA(TM) technology marks a significant step forward in preventing the misuse and abuse of transdermal drugs, addressing a critical aspect of the ongoing opioid crisis.

HeartBeam Inc. Strengthens Cardiac Care Innovation with New Patents
HeartBeam Inc. has secured two new U.S. patents for its 3D ECG and cardiac monitoring technology, marking a significant advancement in remote cardiac diagnostics and enhancing the company's intellectual property portfolio.

HeartBeam Inc. Advances Cardiac Monitoring with New Patents
HeartBeam Inc. has secured two new U.S. patents for its innovative 3D ECG and cardiac monitoring technologies, marking a significant step forward in remote cardiac diagnostics and patient care.

Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology
Nutriband Inc. has been granted a U.S. patent for its Aversa(TM) technology, marking a significant step forward in the fight against drug abuse and misuse with its abuse-deterrent transdermal products.

Femto Technologies Secures Patent Allowance for Innovative Sensera Wellness Device
Femto Technologies Inc. received a Notice of Allowance from the USPTO for its Sensera device design, highlighting a significant milestone in AI-driven female wellness technology that was recently honored with a CES Innovation Award.

ABVC BioPharma Secures Japanese Patent for Innovative Depression Treatment
ABVC BioPharma has obtained a Japanese patent for its botanical-based Major Depressive Disorder treatment ABV-1504, expanding its global intellectual property portfolio and positioning the company for potential market entry in Japan's robust pharmaceutical landscape.

GeoVax Secures New Patent for Innovative Cancer Treatment Approach
GeoVax Labs has received a Notice of Allowance for a patent describing a novel triple-combination cancer therapy strategy targeting solid tumors with potential to minimize systemic toxicity and enhance treatment effectiveness.

Femto Technologies Secures Patent for Smart Release System Technology in Femtech Innovation
Femto Technologies has received a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary Smart Release System technology, reinforcing its position as an AI-driven feminine wellness innovator and highlighting the potential for advanced technology in personal health solutions.

HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies
Medical technology company HeartBeam adds two new U.S. patents to its intellectual property collection, enhancing its capabilities in portable cardiac monitoring and arrhythmia detection technology.

Intellectual Property Experts Highlight Innovation's Role in Global Progress
The Patent Baron PLLC marks World Intellectual Property Day by emphasizing the critical role of IP rights in driving technological advancement and solving global challenges. The firm underscores how protecting innovative ideas can create pathways for sustainable development.

CyberloQ Technologies Achieves SOC 2 Compliance and Files Second Patent, Positioning for Market Expansion
CyberloQ Technologies has secured SOC 2 Type 1 compliance and filed a second patent, signaling strategic moves to enter banking and fintech markets with enhanced multi-factor authentication solutions. These milestones represent a critical transition for the company toward revenue generation and market differentiation.

Nutriband Strengthens Intellectual Property for Abuse-Deterrent Drug Delivery Technology
Nutriband secures new U.S. trademark and international patents for its AVERSA™ transdermal drug delivery platform, positioning the company to target a significant market opportunity in abuse-deterrent pharmaceuticals.

Sweet Living Group Expands Patent Portfolio for Sustainable EcoZinc® Textile Technology
Sweet Living Group has secured 18 U.S. patents for its EcoZinc® technology, positioning the company at the forefront of sustainable textile innovation with eco-friendly, zinc-based fabric compounds that offer multiple performance benefits.